SRX Global (SRXH) Stock: Insider Trades, Congress & Funds

Smart money at a glance

Filings to Nov 14, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: $0
CongressSTOCK Act, 180 days: None
Big funds13F, latest quarter: No large changes
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

No analyst estimates.

Questions about SRXH filings

Are insiders buying or selling SRx Health Solutions Inc. (SRXH) stock?

Neither. SRx Health Solutions Inc. (SRXH) insiders filed no open-market purchases or sales in the 90 days to Nov 14, 2026, according to SEC Form 4 filings.

Which members of Congress have traded SRXH recently?

None. No member of Congress disclosed a SRXH trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this SRXH smart-money data?

This summary uses filings available on Nov 14, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

No recent filings found.

6 funds hold a position.

Questions about SRXH filings

Are insiders buying or selling SRx Health Solutions Inc. (SRXH) stock?

Neither. SRx Health Solutions Inc. (SRXH) insiders filed no open-market purchases or sales in the 90 days to Nov 14, 2026, according to SEC Form 4 filings.

Which members of Congress have traded SRXH recently?

None. No member of Congress disclosed a SRXH trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this SRXH smart-money data?

Checking federal contract awards

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 13, 2026

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 13, 2026

Period ending

Jun 30, 2026

Earnings per share

Unavailable

EPS comparison unavailable

Revenue

$3.4M

SEC filing

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Jun 30, 2026Reported Aug 13, 2026	Not on file	No estimate	$3.4MSEC filing	+26.9%from $2.7M
Mar 31, 2026Reported May 14, 2026	Not on file	No estimate	$3.4MSEC filing	-52.0%from $7.2M
Dec 31, 2025Reported Feb 13, 2026	Not on file	No estimate	$2.8MSEC filing	No year-ago quarter
Jun 30, 2025Reported Sep 30, 2025	Not on file	No estimate	$2.7MSEC filing	-93.7%from $42.7M
Mar 31, 2025Reported May 15, 2025	-$0.37Reported	No estimate	$7.2MSEC filing	+496.6%from $1.2M
Dec 31, 2024Reported Mar 31, 2025	-$0.56est. -$0.10	-$0.46miss	$35.0M · FYSEC filing	No year-ago quarter
Sep 30, 2024Reported Nov 13, 2024	$0.73Reported	No estimate	$11.4MSEC filing	-13.3%from $13.1M
Jun 30, 2024Reported Aug 14, 2024	$2.98Reported	No estimate	$42.7MSEC filing	+305.0%from $10.5M

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $0.92
High: $0.95
Low: $0.88
Prev close: $0.94
52-wk high: $41.55
52-wk low: $0.71
Mkt cap: $17.8M
P/E: 0.0x
ROE: +0.0%
P/S: 0.3x
P/B: 0.1x
Profit margin: +0.0%
Op margin: +0.0%

Fundamentals

Is the business strong?

Fairly priced and running thin margins.

Net margin: 0.0%
P/E: 0.01
Market cap: $18M

Valuation

P/S0.34
P/B0.13
Dividend yield0.0%

Quality

Operating margin0.0%
ROE0.0%
ROA-11.0%

Growth

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

0 / 100

RSI 14

32balanced

20D volatility

72%annualized

52-week range

$0.88

$0.71$41.55

20D support

$0.71recent floor

20D resistance

$1.30recent ceiling

Returns

5D -0.8%20D -31.8%60D -50.8%

Price vs moving averages

SMA20 -13.3%SMA50 -34.7%SMA200 -1.0%

Volume pace

0.59xvs prior 20D

Smart money at a glance

Filings to Nov 14, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: $0
CongressSTOCK Act, 180 days: None
Big funds13F, latest quarter: No large changes
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

No analyst estimates.

Questions about SRXH filings

Are insiders buying or selling SRx Health Solutions Inc. (SRXH) stock?

Neither. SRx Health Solutions Inc. (SRXH) insiders filed no open-market purchases or sales in the 90 days to Nov 14, 2026, according to SEC Form 4 filings.

Which members of Congress have traded SRXH recently?

None. No member of Congress disclosed a SRXH trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this SRXH smart-money data?

No recent filings found.

6 funds hold a position.

Questions about SRXH filings

Are insiders buying or selling SRx Health Solutions Inc. (SRXH) stock?

Neither. SRx Health Solutions Inc. (SRXH) insiders filed no open-market purchases or sales in the 90 days to Nov 14, 2026, according to SEC Form 4 filings.

Which members of Congress have traded SRXH recently?

None. No member of Congress disclosed a SRXH trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this SRXH smart-money data?

Checking federal contract awards

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 13, 2026

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 13, 2026

Period ending

Jun 30, 2026

Earnings per share

Unavailable

EPS comparison unavailable

Revenue

$3.4M

SEC filing

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Jun 30, 2026Reported Aug 13, 2026	Not on file	No estimate	$3.4MSEC filing	+26.9%from $2.7M
Mar 31, 2026Reported May 14, 2026	Not on file	No estimate	$3.4MSEC filing	-52.0%from $7.2M
Dec 31, 2025Reported Feb 13, 2026	Not on file	No estimate	$2.8MSEC filing	No year-ago quarter
Jun 30, 2025Reported Sep 30, 2025	Not on file	No estimate	$2.7MSEC filing	-93.7%from $42.7M
Mar 31, 2025Reported May 15, 2025	-$0.37Reported	No estimate	$7.2MSEC filing	+496.6%from $1.2M
Dec 31, 2024Reported Mar 31, 2025	-$0.56est. -$0.10	-$0.46miss	$35.0M · FYSEC filing	No year-ago quarter
Sep 30, 2024Reported Nov 13, 2024	$0.73Reported	No estimate	$11.4MSEC filing	-13.3%from $13.1M
Jun 30, 2024Reported Aug 14, 2024	$2.98Reported	No estimate	$42.7MSEC filing	+305.0%from $10.5M

Open: $0.92
High: $0.95
Low: $0.88
Prev close: $0.94
52-wk high: $41.55
52-wk low: $0.71
Mkt cap: $17.8M
P/E: 0.0x
ROE: +0.0%
P/S: 0.3x
P/B: 0.1x
Profit margin: +0.0%
Op margin: +0.0%

Fundamentals

Is the business strong?

Fairly priced and running thin margins.

Net margin: 0.0%
P/E: 0.01
Market cap: $18M

Valuation

P/S0.34
P/B0.13
Dividend yield0.0%

Quality

Operating margin0.0%
ROE0.0%
ROA-11.0%

Growth

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

0 / 100

RSI 14

32balanced

20D volatility

72%annualized

52-week range

$0.88

$0.71$41.55

20D support

$0.71recent floor

20D resistance

$1.30recent ceiling

Returns

5D -0.8%20D -31.8%60D -50.8%

Price vs moving averages

SMA20 -13.3%SMA50 -34.7%SMA200 -1.0%

Volume pace

0.59xvs prior 20D

SRx Health Solutions Inc.

Smart money at a glance

What do analysts expect?

Questions about SRXH filings

Questions about SRXH filings

How top traders are positioned

Unlock everything for $29/month

Results versus expectations

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

SRx Health Solutions Inc.

Smart money at a glance

What do analysts expect?

Questions about SRXH filings

Questions about SRXH filings

How top traders are positioned

Unlock everything for $29/month

Results versus expectations

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

SRx Health Solutions Inc.

Overview

Questions about SRXH filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

SRx Health Solutions Inc.

Overview

Questions about SRXH filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.